Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells.
Transforming growth-interacting factor (TGIF) is a homeobox transcriptional repressor that has been implicated in holoprosencephaly and various types of cancer. TGIF is expressed in hematopoietic stem cells and modulates TGF-beta and retinoic acid (RA) signaling, both of which play an important role in hematopoiesis. We recently reported that TGIF's levels correlate inversely with survival in patients with acute myelogenous leukemia. Here we present the first direct evidence of a role for TGIF in myelopoiesis. We used short hairpin RNA interference to define the effects of TGIF knockdown on proliferation and differentiation of myeloid leukemia-derived cell lines. Decreased TGIF expression resulted in reduced proliferation and differentiation and lower expression of CEBPbeta, CEBPepsilon, PU.1 and RUNX1, key myeloid transcription factors. Furthermore, TGF-beta signaling was increased and RA signaling was decreased. Further insights into the molecular basis of TGIF's effects were provided by a genome-wide chromatin immunoprecipitation-based elucidation of TGIF target genes. Together, these data suggest that TGIF has an important role myelopoiesis and may regulate the balance between proliferation and differentiation. Reduced TGIF expression could tip the balance toward quiescence thus providing progenitor as well as hematopoietic stem cells protection from anti-cycle agents.
Hamid
Rizwan
R
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, United States. rizwan.hamid@vanderbilt.edu
Brandt
Stephen J
SJ
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D002453:Cell Cycle / Q000502:physiology; D002454:Cell Differentiation / Q000502:physiology*; D049109:Cell Proliferation; D055785:Gene Knockdown Techniques; D018922:HL-60 Cells; D018398:Homeodomain Proteins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007951:Leukemia, Myeloid / Q000378:metabolism / Q000473:pathology; D051379:Mice; D038042:Myelopoiesis / Q000502:physiology*; D034622:RNA Interference; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism; D014212:Tretinoin / Q000378:metabolism
D018398:Homeodomain Proteins; D012097:Repressor Proteins; C097504:TGIF1 protein, human; D014157:Transcription Factors; D016212:Transforming Growth Factor beta; D014212:Tretinoin
Cell. 1999 Apr 2;97(1):29-39
10199400
Nat Genet. 1999 Jun;22(2):196-8
10369266
Blood. 1997 Mar 15;89(6):2113-21
9058734
Leukemia. 2002 Oct;16(10):1896-905
12357341
BMC Genomics. 2007 May 31;8:139
17540029
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):749-54
15640349
Nat Rev Immunol. 2007 Feb;7(2):105-17
17259967
Nat Biotechnol. 1997 Sep;15(9):871-5
9306402
Mol Cell Biol. 2006 Jun;26(11):4302-10
16705179
Exp Hematol. 1999 Sep;27(9):1355-67
10480426
Immunity. 2007 Jun;26(6):726-40
17582345
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13424-9
14581620
J Cell Sci. 2000 Feb;113 ( Pt 3):383-90
10639326
Cell. 1993 Sep 24;74(6):1009-20
8402878
Cell. 2005 May 6;121(3):335-48
15882617
Science. 2000 Jun 2;288(5471):1635-40
10834841
J Lipid Res. 2008 Jun;49(6):1224-34
18310014
Biochem Biophys Res Commun. 1998 Nov 18;252(2):368-72
9826536
Mol Cancer Res. 2003 Jun;1(8):619-30
12805409
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13187-92
9371821
J Biochem Mol Biol. 2002 Jan 31;35(1):47-53
16248969
J Immunol. 1990 Mar 1;144(5):1767-76
2407783
Dev Biol. 2003 Aug 15;260(2):404-13
12921741
Blood. 2006 Apr 15;107(8):3330-8
16352814
Oncogene. 2008 Oct 20;27(48):6299-312
18931695
Cell Physiol Biochem. 2009;23(1-3):157-64
19255510
Nat Genet. 1998 Oct;20(2):180-3
9771712
Cell Growth Differ. 2001 Sep;12(9):457-63
11571228
Cell. 2006 Mar 24;124(6):1283-98
16564017
Mol Ther. 2000 Aug;2(2):170-6
10947945
J Biol Chem. 1999 Dec 24;274(52):37105-10
10601270
Science. 1996 Apr 12;272(5259):263-7
8602510
J Biol Regul Homeost Agents. 2003 Jan-Mar;17(1):46-65
12757021
Exp Hematol. 2005 Sep;33(9):1055-61
16140154
J Biol Chem. 1995 Dec 29;270(52):31178-88
8537382
PPAR Res. 2007;2007:87934
17846663
Mol Oncol. 2009 Dec;3(5-6):451-63
19699159
Oncogene. 2008 Apr 7;27(16):2289-99
18391971
Curr Protoc Immunol. 2005 Jul;Chapter 22:Unit 22F.5
18432952
Leukemia. 2003 Sep;17(9):1731-7
12970772
Oncogene. 2005 Aug 29;24(37):5676-92
16123801
Hum Genet. 2002 May;110(5):422-8
12073012
Mol Cell. 2006 Aug;23(4):547-59
16916642
Blood. 1996 Jul 1;88(1):82-8
8704205
Nat Genet. 1996 Nov;14(3):353-6
8896571
Oncogene. 2001 Oct 29;20(49):7178-85
11704846
Hum Genet. 2002 Apr;110(4):297-301
11941477
Mol Cell Biol. 2006 Feb;26(3):990-1001
16428452
Biochim Biophys Acta. 2008 May;1779(5):347-55
18455519
Br J Haematol. 1997 Dec;99(4):951-8
9432049
RNA. 2003 Apr;9(4):493-501
12649500
J Cell Physiol. 1989 Oct;141(1):65-73
2789227
EMBO J. 2008 Jul 9;27(13):1804-15
18511908
Blood. 1999 Nov 1;94(9):3141-50
10556201